Breast cancer survivors must remain vigilant for recurrence signs, which can manifest locally, regionally, or distantly. New ...

While traditional induction therapy for newly diagnosed stage 2 myeloma often focuses on combinations of proteasome inhibitors, immunomodulatory drugs, and steroids, these newer immunotherapy classes ...

Breast cancer is the most common cancer in women, so it's vital to know the signs and symptoms to look out for - and how to ...

We speak to a nurse to find out about the signs and symptoms of breast cancer, plus how to conduct a breast self examination ...

(WYTV)- Researchers at the Cleveland Clinic have been looking at bone cancer in children and young adults. They’ve found a gene that will increase the risk of developing it. They analyzed genetic ...

Survival rates for children with multi-metastatic Ewing’s sarcoma — a kind of bone cancer which has spread to multiple parts of the body — are ‘dismal’, scientists say. The five-year survival rate for ...

The young athlete is sidelined after a life-changing diagnosis, but he is adapting and looking ahead. Secret Service finds 17 'skimming' devices in tour of San Antonio businesses Bombshell report ...

Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and spinal cord)—are known to infiltrate and grow within malignant bone tumors ...

Study in @PNASNews (bit.ly/4oK42vm) from @HopkinsMedicine @JHUPath shows in mice that two @US_FDA-approved pain drugs also inhibit nerve signaling/blood vessel formation in #Osteosarcomas & slow ...

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved treatments, prompting the San Diego biotech to plot a submission to the FDA ...

Oct 23 (Reuters) - Inhibrx Biosciences (INBX.O), opens new tab said on Thursday its experimental drug helped slow the progression of a rare and aggressive bone cancer in a mid-stage trial, sending its ...